摘要
TRPM7(transient receptor potential melastatin 7)通道属于TRPM亚家族,是一种具有离子通道结构域和激酶结构域的双功能跨膜蛋白。作为非选择性阳离子通道,TRPM7可通透Ca^(2+)、Mg^(2+)、Zn^(2+)、Na+、K+等和其他微量金属离子。TRPM7在人体各组织广泛表达,参与Mg^(2+)的稳态调控、细胞增殖、分化、黏附和迁移等生理过程。临床上,TRPM7功能紊乱与神经退行性疾病、中风、癌症等多种疾病关系密切。本文主要综述TRPM7通道在生理、病理及小分子调节剂方面的研究进展,为相关疾病的药物开发提供新的思路。
Transient receptor potential melastatin 7(TRPM7),a member of the TRPM subfamily,is a ubiquitously expressed bifunctional transmembrane protein with a channel domain fused to an active kinase domain.As a non-selective cation channel,TRPM7 is permeable to Ca^(2+),Mg^(2+),Zn^(2+),Na+,K+,and other trace metals.As anα-kinase,TRPM7 can autophosphorylate its serine and threonine residues,or phosphorylate endogenously targeted substrates such as myosin II.Through the joint action of the two domains,TRPM7 participates in various physiological processes such as Mg^(2+)homeostasis regulation,cell proliferation,differentiation,adhesion and migration,and ultimately affects cell differentiation and embryonic development.Dysfunction of TRPM7 has been associated with multiple neurodegenerative diseases,tissue fibrosis,ischemic injury as well as the occurrence and development of tumors.Genetic or pharmacological deficit of the TRPM7 relieves ischemic neuronal injury and inhibits the proliferation and migration of tumors,while up-regulating or restoring TRPM7 decreases blood pressure,maintains normal embryonic development and may be an effective strategy to treat the neurodegenerative disorders.However,whether TRPM7 is a promising target for the development of clinical drugs remains elusive.Nowadays,several small molecules display activation or inhibitory activities on the TRPM7 channel,and have been successfully used to uncover new cellular roles of TRPM7 in physiological and pathological conditions.Nonetheless,selective and potent TRPM7 modulators are limited.This review summarizes the research progress on the physiological and pathological functions of TRPM7 and its small-molecule modulators,which may provide new therapeutic strategies for TRPM7-related diseases and new directions for the development of novel TRPM7 regulators.
作者
王云起
官子月
高召兵
郑月明
WANG Yun-Qi;GUAN Zi-Yue;GAO Zhao-Bing;ZHENG Yue-Ming(Center for Neurological and Psychiatric and Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China)
出处
《生物化学与生物物理进展》
SCIE
CSCD
北大核心
2023年第12期2856-2868,共13页
Progress In Biochemistry and Biophysics
基金
国家杰出青年科学基金(81825021)
中国科学院青年创新促进会(2020284)资助项目。